NasdaqGS - Nasdaq Real Time Price USD

Neurocrine Biosciences, Inc. (NBIX)

Compare
116.08 +0.56 (+0.48%)
At close: October 25 at 4:00 PM EDT
116.08 0.00 (0.00%)
After hours: October 25 at 4:37 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,119,500.00
1,887,100.00
1,488,700.00
1,133,500.00
1,045,900.00
Cost of Revenue
36,400.00
39,700.00
23,200.00
14,300.00
10,100.00
Gross Profit
2,083,100.00
1,847,400.00
1,465,500.00
1,119,200.00
1,035,800.00
Operating Expense
1,538,400.00
1,452,600.00
1,216,500.00
911,400.00
708,300.00
Operating Income
544,700.00
394,800.00
249,000.00
207,800.00
327,500.00
Net Non Operating Interest Income Expense
--
-4,600.00
-7,100.00
-25,800.00
-32,800.00
Other Income Expense
-93,200.00
-58,100.00
-28,000.00
-80,600.00
-188,000.00
Pretax Income
446,900.00
332,100.00
213,900.00
101,400.00
106,700.00
Tax Provision
107,700.00
82,400.00
59,400.00
11,800.00
-300,600.00
Net Income Common Stockholders
339,200.00
249,700.00
154,500.00
89,600.00
407,300.00
Diluted NI Available to Com Stockholders
339,200.00
249,700.00
154,500.00
89,600.00
407,300.00
Basic EPS
3.45
2.56
1.61
0.95
4.38
Diluted EPS
3.32
2.47
1.56
0.92
4.16
Basic Average Shares
99,150.00
97,700.00
95,800.00
94,600.00
93,100.00
Diluted Average Shares
102,750.00
101,000.00
98,900.00
97,900.00
97,800.00
Total Operating Income as Reported
536,200.00
250,900.00
249,000.00
102,500.00
163,000.00
Total Expenses
1,574,800.00
1,492,300.00
1,239,700.00
925,700.00
718,400.00
Net Income from Continuing & Discontinued Operation
339,200.00
249,700.00
154,500.00
89,600.00
407,300.00
Normalized Income
409,939.40
293,384.34
174,724.40
160,820.51
544,540.00
Interest Expense
--
4,600.00
7,100.00
25,800.00
32,800.00
Net Interest Income
--
-4,600.00
-7,100.00
-25,800.00
-32,800.00
EBIT
486,600.00
336,700.00
221,000.00
127,200.00
139,500.00
EBITDA
511,300.00
358,000.00
236,600.00
138,100.00
148,100.00
Reconciled Cost of Revenue
36,400.00
39,700.00
23,200.00
14,300.00
10,100.00
Reconciled Depreciation
24,700.00
21,300.00
15,600.00
10,900.00
8,600.00
Net Income from Continuing Operation Net Minority Interest
339,200.00
249,700.00
154,500.00
89,600.00
407,300.00
Total Unusual Items Excluding Goodwill
-93,200.00
-58,100.00
-28,000.00
-80,600.00
-188,000.00
Total Unusual Items
-93,200.00
-58,100.00
-28,000.00
-80,600.00
-188,000.00
Normalized EBITDA
604,500.00
416,100.00
264,600.00
218,700.00
336,100.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-22,460.60
-14,415.66
-7,775.60
-9,379.49
-50,760.00
12/31/2020 - 5/23/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers